Zafirlukast (Dr. Reddys Laboratories Limited)


Welcome to the PulseAid listing for the Zafirlukast drug offered from Dr. Reddys Laboratories Limited. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr. Reddys Laboratories Limited
NON-PROPRIETARY NAME: Zafirlukast
SUBSTANCE NAME: ZAFIRLUKAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-11-18
END MARKETING DATE: 0000-00-00


Zafirlukast HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZafirlukast from Dr. Reddys Laboratories Limited
LABELER NAME: Dr. Reddys Laboratories Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2010-11-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55111-625_f8d7ff01-8167-c19d-4889-c944fb9dc74c
PRODUCT NDC: 55111-625
APPLICATION NUMBER: ANDA090372

Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingZafirlukast
AstraZeneca Pharmaceuticals LPACCOLATE
Avera McKennan HospitalZafirlukast
AvPAKZafirlukast
Carilion Materials ManagementZafirlukast
Dr. Reddys Laboratories LimitedZafirlukast
Par Pharmaceutical Inc.ZAFIRLUKAST
State of Florida DOH Central PharmacyACCOLATE